ABDALLA MD ISMAIL
Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology CANTON, OH NPI 1962964031
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology OH NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$304.21
- Category: General Payments
- Program years: PY2023–2024
- Record count: 14
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $175.11 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $175.11 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $59.79 | 3 |
| NXSTAGE MEDICAL, INC. | $36.26 | 2 |
| GlaxoSmithKline, LLC. | $29.05 | 1 |
| Otsuka America Pharmaceutical, Inc. | $27.60 | 1 |
| Aurinia Pharma U.S., Inc. | $22.41 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1086958605 | Novartis Pharmaceuticals Corporation | $16.67 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086958607 | Novartis Pharmaceuticals Corporation | $23.57 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086958615 | Novartis Pharmaceuticals Corporation | $19.55 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1115935698 | GlaxoSmithKline, LLC. | $29.05 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118912845 | Otsuka America Pharmaceutical, Inc. | $27.60 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150683337 | Aurinia Pharma U.S., Inc. | $22.41 | 03/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1154282713 | NXSTAGE MEDICAL, INC. | $16.66 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1154282715 | NXSTAGE MEDICAL, INC. | $19.60 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.